Bile Acids, Liver Injury, and Liver Disease

Archives of Internal Medicine

Volumn 130, Issue 4, 1972, Pages 606-617

  Palmer, Robert H ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BILE ACID; COLESTYRAMINE; NEOMYCIN;

ANIMAL; BILE DUCT FISTULA; BLOOD; CHICKEN; DRUG EFFECT; HAMSTER; HAPLORHINI; HUMAN; IN VITRO STUDY; INJURY; LIVER; LIVER DISEASE; METABOLISM; PERFUSION; RABBIT; RAT; REVIEW;

ANIMAL; BILE ACIDS AND SALTS; BILIARY FISTULA; CHICKENS; CHOLESTYRAMINE; HAMSTERS; HAPLORHINI; HUMAN; IN VITRO; LIVER; LIVER DISEASES; NEOMYCIN; PERFUSION; RABBITS; RATS;

EID: 0015415107     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinte.1972.03650040130012     Document Type: Article

References (111)

1. Horrall OH: Bile: Its Toxicity and Relation to Disease. Chicago, University of Chicago Press, 1938.
2. Kappas A, Palmer RH: Selected aspects of steroid pharmacology. Pharmacol Rev 15:123-167, 1963.
3. Palmer RH: Toxic effects of lithocholic acid and related 5β-H steroids, in Schiff L, Carey JB Jr, Dietschy JM (eds.): Bile Salt Metabolism. Springfield, Charles C Thomas, Publisher, 1969, pp 184-204.
4. Holsti P: Experimental cirrhosis of the liver in rabbits induced by gastric instillation of desiccated whole bile. Acta Path Microbiol Scand 112(suppl):1-67, 1956.
5. Holsti P: Zirrhogene Einwirkung von Gallensäurenerbindungen. Naturwiss 45:165, 1958.
6. Holsti P: Further investigations on the cirrhogenic effect of a desiccated whole bile preparation. Acta Path Microbiol Scand 50:377-382, 1960.
7. Holsti P: Cirrhosis of the liver induced in rabbits by gastric instillation of 3-monohydroxycholanic acid. Nature 186:250, 1960.
8. Holsti P: Bile acids as a cause of liver injury— cirrhogenic effect of chenodeoxycholic acid in rabbits. Acta Path Microbiol Scand 54:479, 1962.
9. Hunt RD, Leveille GA, Sauberlich HE: Dietary bile acids and lipid metabolism: III. Effects of lithocholic acid in mammalian species. Proc Soc Exp Biol Med 115:277-280, 1964.
10. Hunt RD: Proliferation of bile ductules (the ductular cell reaction) induced by lithocholic acid. Fed Proc 24:431, 1965.
11. Stolk A: Induction of hepatic cirrhosis in Iguana iguana by 3-mono-hydroxycholanic treatment. Experientia 16:507, 1960.
12. Stolk A: Induction of hepatic cirrhosis in the axoloth by 3-mono-hydroxycholanic treatment. Naturwiss 48:671, 1961.
13. Jakowska S, Fagundo PP: Mucus hypersecretion and other effects of lithocholic acid in the newt, Notophthalmus viridescens (Rafinesque). Amer Zool 6:264, 1966.
14. Leveille GA, Sauberlich HE, Hunt RD: Effect of dietary lithocholic acid on liver size of the chick. Poult Sci 41:1991-1992, 1962.
15. Leveille GA, Sauberlich HE, Hunt RD: Dietary bile acids and lipid metabolism: I. Influence on lipids and liver size of chicks. Proc Soc Exp Biol Med 114:334-337, 1963.
16. Hunt RD, Leveille GA, Sauberlich HE: Dietary bile acids and lipid metabolism: II. The ductular cell reaction induced by lithocholic acid. Proc Soc Exp Biol Med 113:139-142, 1963.
17. Eyssen H, De Sommer P: Toxicity of lithocholic acid for the chick. Poult Sci 42:1020-1022, 1963.
18. Leveille GA, Hunt RD, Sauberlich HE: Dietary bile acids and lipid metabolism: IV. Dietary level of lithocholic acid for chicks. Proc Soc Exp Biol Med 115:569-572, 1964.
19. Leveille GA, Hunt RD, Sauberlich HE: Dietary bile acids and lipid metabolism: V. Reversibility of the effects of lithocholic acid in chicks. Proc Soc Exp Biol Med 115:573-574, 1964.
20. Eyssen H, Vandeputte M, Evrard E: Effect of various dietary bile acids on nutrient absorption and on liver size in chicks. Arch Int Pharmacodyn 158:292-306, 1965.
21. Leveille GA, King NW, Sauberlich HE, et al: Induction and regression of biochemical and morphologic changes induced by lithocholic acid in chickens. Amer J Vet Res 119:1045-1052, 1966.
22. Eyssen H, Vandeputte M: Histological changes induced in the liver of rats fed lithocholic acid. Read before the International Conference on the Biochemistry of Lipids, Stockholm, Aug 5-7, 1963.
23. Palmer RH: Gallstones produced experimentally by lithocholic acid in rats. Science 148:1339, 1965.
24. Palmer RH, Hruban Z: Production of bile duct hyperplasia and gallstones by lithocholic acid. J Clin Invest 45:1255-1267, 1966.
25. Carey JB Jr, Wilson ID, Zaki FG, et al: The metabolism of bile acids with special reference to liver injury. Medicine 45:461-470, 1966.
26. Zaki FG, Carey JB Jr, Hoffbauer FW, et al: Biliary reaction and choledocholithiasis induced in the rat by lithocholic acid. J Lab Clin Med 69:737-748, 1967.
27. Silverberg M, Solomon L, Ehrlich JC: The hepatotoxic effects of lithocholic acid in the new born hamster. Gastroenterology 60:753, 1971.
28. Cooper RA, Admirand WH, Garcia FA, et al: The role of lithocholic acid in the pathogenesis of spur red cells and hemolytic anemia. J Clin Invest 18:18a, 1969.
29. Palmer RH: Experimental cholelithiasis, in Nair PP, Kritchevsky D (eds.): The Bile Acids— Chemistry, Physiology and Metabolism. New York, Plenum Press, vol 2, to be published.
30. Sharp H, Carey J, Peller J, et al: Lithocholic acid in meconium. Pediat Res 2:293, 1968.
31. Ahlberg JW: The Metabolism of14C Bile Acids in the Chicken, thesis. Saint Louis University, St. Louis, 1964. US Doctoral Dissertation Abstracts 25:4379, 1965.
32. Ivy AC: The applied physiology of bile secretion and bile salt therapy. JAMA 117:1151-1154, 1941.
33. Javitt NB: Cholestasis in rats induced by taurolithocholate. Nature 210:1262-1263, 1966.
34. Javitt NB, Emerman S: Effect of sodium taurolithocholate on bile flow and bile acid excretion. J Clin Invest 47:1002-1014, 1968.
35. Schaffner F, Javitt NB: Morphologic changes in hamster liver during intrahepatic cholestasis induced by taurolithocholate. Lab Invest 15:1783-1792, 1966.
36. King JE, Schoenfield LJ: Cholestasis induced by sodium taurolithocholate in isolated hamster liver. J Clin Invest 50:2305-2312, 1971.
37. Fisher MM, Magnusson R, Miyai K: Bile acid metabolism in mammals: I. Bile acid-induced intrahepatic cholestasis. Lab Invest 25:88-91, 1971.
38. Fisher MM, Phillips MJ: Sex difference in chenodeoxycholate metabolism in rats. Gastroenterology 66:742, 1971.
39. Miyai K, Price VM, Fisher MM: Bile acid metabolism in mammals. Ultrastructural studies on the intrahepatic cholestasis induced by lithocholic and chenodeoxycholic acids in the rat. Lab Invest 24:292-302, 1971.
40. Weissmann G, Keiser H: Hemolysis and augmentation of hemolysis by neutral steroids and bile acids. Biochem Pharmacol 14:537-546, 1965.
41. Weissmann G: Studies of lysosomes: VI. The effect of neutral steroids and bile acids on lysosomes in vitro. Biochem Pharmacol 14:525-535, 1965.
42. Weissmann G, Sessa G, Standish M, et al: A direct effect of steroids on the permeability of lipid membranes (liposomes). J Clin Invest 44:1109, 1965.
43. Lee MJ, Whitehouse MW: Inhibition of electron transport and coupled phosphorylation in liver mitochondria by cholanic (bile) acids and their conjugates. Biochim Biophys Acta 100:317-328, 1965.
44. Rudman D, Kendall FE: Bile acid content of human serum: II. The binding of cholanic acids by human plasma proteins. J Clin Invest 36:538-542, 1957.
45. Hutterer F, Denk H, Bacchin PG, et al: Mechanism of cholestasis: I. Effect of bile acids on microsomal cytochrome P-450 dependent biotransformation system in vitro. Life Sci 9:877-887, 1970.
46. Hutterer F, Bacchin PG, Denk H, et al: Mechanism of cholestasis: 2. Effect of bile acids on the microsomal electron transfer system in vitro. Life Sci 9:1159-1166, 1970.
47. Thistle JL, Schoenfield LJ: Induced alterations in composition of bile of persons having cholelithiasis. Gastroenterology 61:488-496, 1971.
48. Mekhjian HS, Phillips SF, Hofmann AF: Colonic secretion of water and electrolytes induced by bile acids: Perfusion studies in man. J Clin Invest 50:1569-1577, 1971.
49. Parkinson TM, Olson JA: Inhibitory effects of bile acids on adenosine triphosphatase, oxygen consumption, and the transport and diffusion of water-soluble substances in the small intestine of the rat. Life Sci 3:107-112, 1964.
50. Faust RG, Wu SML: The action of bile salts on fluid and glucose movement by rat and hamster jejunum in vitro. J Cell Comp Physiol 65:435-448, 1965.
51. Faust RG, Wu SML: The effect of bile salts on tissue ATP levels of everted sacs of rat and hamster ileum. J Cell Comp Physiol 65:449-452, 1965.
52. Erlinger S, Dumont M, Dhumeaux D, et al: The effect on bile formation of inhibitors of Na+-K+-adenosine triphosphatase (Na+-K+-ATPase). Gastroenterology 58:1028, 1970.
53. Faust RG, Wu SML: The effect of bile salts on oxygen consumption, oxidative phosphorylation and ATP-ase activity of mucosal homogenates from rat jejunum and ileum. J Cell Physiol 67:149-158, 1966.
54. Kaplan MM, Righetti A: Induction of rat liver alkaline phosphatase: The mechanism of the serum elevation in bile duct obstruction. J Clin Invest 49:508-516, 1970.
55. Voigt W, Thomas PJ, Hsia SL: Enzymic studies of bile acid metabolism: I. 6β-hydroxylation of chenodeoxycholic and taurochenodeoxycholic acids by microsomal preparations of rat liver. J Biol Chem 243:3493-3499, 1968.
56. Remmer H: The role of the liver in drug metabolism. Amer J Med 49:617-629, 1970.
57. Denk H, Schenkman JB, Bacchin PG, et al: Mechanism of cholestasis: III. Interaction of synthetic detergents with the microsomal cytochrome P-450 dependent biotransformation system in vitro. Exp Molec Path 14:263-276, 1971.
58. Schaffner F, Bacchin PG, Hutterer F, et al: Mechanism of cholestasis: IV. Structural and biochemical changes in the liver and serum in rats after bile duct ligation. Gastroenterology 60:888-897, 1971.
59. Okishio T, Nair PP: Studies on bile acids: Some observations on the intracellular localization of major bile acids in rat liver. Biochemistry 5:3662-3668, 1966.
60. Schaffner F, Popper H: Hypothesis: Cholestasis is the result of hypoactive hypertrophic smooth endoplasmic reticulum in the hepatocyte. Lancet 2:355-359, 1969.
61. Schaffner F: The molecular basis of cholestasis. Digestion 4:117-120, 1971.
62. Carey JB Jr, Wilson ID, Onstad G, et al: Role of 12α-hydroxylase deficiency in continuing liver injury. J Clin Invest 46:1042, 1967.
63. Javitt N: Bile salt regulation of hepatic excretory function. Gastroenterology 56:622-625, 1969.
64. Dillard GM, Bodel P: Studies on steroid fever: II. Pyrogenic and anti-pyrogenic activity in vitro of some endogenous steroids of man. J Clin Invest 49:2418-2426, 1970.
65. Dawson AM, Isselbacher KJ: Studies on lipid metabolism in the small intestine with observations on the role of bile salts. J Clin Invest 39:730-740, 1960.
66. Small DM, Admirand W: Solubility of bile salts. Nature 221:265-267, 1969.
67. Palmer RH, Bolt MG: Bile acid sulfates: I. Synthesis of lithocholic acid sulfates and their identification in human bile. J Lipid Res 12:671-679,1971.
68. Weissmann G: The role of lysosomes in inflammation and disease. Ann Rev Med 18:97-112, 1967.
69. Nair PP, Garcia-Lilis C, Mendeloff AI: Effect of lithocholic acid and antibiotics on tissue bile acids in the rat. J Nutr 100:698-704, 1970.
70. Palmer RH: Bile acid sulfates: II. Formation, metabolism, and excretion of lithocholic acid sulfates in the rat. J Lipid Res 12:680-687, 1971.
71. Mitropoulos KA, Myant NB: The formation of lithocholic acid, chenodeoxycholic acid and α- and βmuricholic acids from cholesterol incubated with ratliver mitochondria. Biochem J 103:472-479, 1967.
72. Wachtel N, Emerman S, Javitt NB: Metabolism of cholest-5-ene-3β,26-diol in the rat and hamster. J Biol Chem 243:5207-5212, 1968.
73. Mujtaba SH, Herndon BL, Kelley MT, et al: Detection of monohydroxy “bile” acids in the brains of guinea pigs afflicted with experimental allergic encephalomyelitis. J Lipid Res 10:115-120, 1969.
74. Danielsson H, Eneroth P, Hellström K, et al: On the turnover and excretory products of cholic and chenodeoxycholic acid in man. J Biol Chem 238:2299-2304, 1963.
75. Palmer RH: The formation of bile acid sulfates: A new pathway of bile acid metabolism in humans. Proc Nat Acad Sci USA 58:1047-1050, 1967.
76. Low-Beer TS, Tyor MP, Lack L: Effects of sulfation of taurolithocholic and glycolithocholic acids on their intestinal transport. Gastroenterology 56:721-726, 1969.
77. Carey JB Jr, Williams G: Metabolism of lithocholic acid in bile fistula patients. J Clin Invest 42:450-455, 1963.
78. Norman A, Palmer RH: Metabolites of lithocholic acid-24-C14 in human bile and feces. J Lab Clin Med 63:986-1001, 1964.
79. Sherlock S, Walshe V: Blood cholates in normal subjects and in liver disease. Clin Sci 5:224-234,1948.
80. Carey JB Jr: Serum trihydroxy-dihydroxy bile acid ratio in liver and biliary tract disease. J Clin Invest 37:1494-1503, 1958.
81. Rudman D, Kendall FE: Bile acid content of human serum: I. Serum bile acids in patients with hepatic disease. J Clin Invest 36:530-537, 1957.
82. Wooton IDP, DaSilva LC, Sherlock S: Serum bile acid levels in liver disease. Lancet 2:1049-1053, 1959.
83. Carey JB Jr: Bile salts and hepatobiliary disease, in Schiff L (ed.): Diseases of the Liver, ed 3. Philadelphia, JB Lippincott Co, 1969, pp 103-146.
84. Makino S, Nakagawa S, Mashimo K: Conjugated and unconjugated serum bile acid levels in patients with hepatobiliary diseases. Gastroenterology 56:1033-1039, 1969.
85. Neale G, Lewis B, Weaver V, et al: Serum bile acids in liver disease. Gut 12:145-152, 1971.
86. Carey JB Jr, Hanson RM, Monson BK: Primary bile salt synthesis in human liver injury. Gastroenterology 56:1142, 1969.
87. Carey JB Jr, Williams G: Lithocholic acid in human-blood serum. Science 150:620-622, 1965.
88. Hayaishi O, Sato Y, Jakoby WB, et al: Reversible enzymatic oxidation of bile acids. Arch Biochem 56:554-555, 1955.
89. Admirand WH, Trey C: Lithocholate levels in diseased human liver. Clin Res 16:278, 1968.
90. Williams CN, Kay R, Senior JR: Progressive fatal familial biliary cirrhosis and bile acid metabolism. Gastroenterology 60:178, 1971.
91. Scherstén T: The synthesis of cholic acid conjugates in human liver. Acta Chir Scand 373(suppl):1-38, 1967.
92. Sandberg DH, Sjövall J, Sjövall K, et al: Measurement of human serum bile acids by gas-liquid chromatography. J Lipid Res 6:182-192, 1965.
93. Lewis B, Panveliwalla D, Tabaqchali S, et al: Serum-bile-acids in the stagnant-loop syndrome. Lancet 1:219-220, 1969.
94. Martini GA, Phear EA, Ruebner B, et al: The bacterial content of the small intestine in normal and cirrhotic subjects: Relation to methionine toxicity. Clin Sci 16:35-51, 1957.
95. Gorbach SL, Lal D, Levitan R: Intestinal microflora in Laennec's cirrhosis. J Clin Invest 49:36a, 1970.
96. Panveliwalla D, Lewis B, Wooton IDP, et al: Determination of individual bile acids in biological fluids by thin-layer chromatography and fluonmetry. J Clin Path 23:309-314, 1970.
97. Sjövall J: Dietary glycine and taurine on bile acid conjugation in man. Proc Soc Exp Biol Med 100:676-678, 1959.
98. McLeod GM, Wiggins HS: Bile salts in small intestinal contents after ileal resection and other malabsorption syndromes. Lancet 1:873-876, 1968.
99. Garbutt JT, Heaton KW, Lack L, et al: Increased ratio of glycine- to taurine-conjugated bile salts in patients with ileal disorders. Gastroenterology 56:711-720, 1969.
100. Sjövall J: Bile acids in man under normal and pathological conditions. Bile acids and steroids 73. Clin Chim Acta 5:33-41, 1960.
101. Theodor E, Spritz N, Sleisenger MH: Metabolism of intravenously injected isotopic cholic acid in viral hepatitis. Gastroenterology 55:183-190, 1968.
102. Vlahcevic ZR, Buhac I, Farrar JT, et al: Bile acid metabolism in patients with cirrhosis: I. Kinetic aspects of cholic acid metabolism. Gastroenterology 60:491-498, 1971.
103. Blum M, Spritz N: The metabolism of intravenously injected isotopic cholic acid in Laennec's cirrhosis. J Clin Invest 45:187-193, 1966.
104. Norman A, Strandvik B, Zetterström R: Bile acid excretion and malabsorption in intrahepatic cholestasis of infancy (“Neonatal Hepatitis”). Acta Paediat Scand 58:59-72, 1969.
105. Admirand WH, Stiehl A, Thaler MM: Sulfation of bile salts: An important metabolic pathway in cholestasis. Gastroenterology 62:190, 1972.
106. Visintine RE, Michaels GD, Fukayama G, et al: Xanthomatous biliary cirrhosis treated with cholestyramine: Bile-acid-adsorbing resin. Lancet 2:341-343, 1961.
107. Lottsfeldt FI, Krivit W, Aust JB, et al: Cholestyramine therapy in intrahepatic biliary atresia. New Eng J Med 269:186-189, 1963.
108. Schaffner F, Klion FM, Latuff AJ: The long-term use of cholestyramine in the treatment of primary biliary cirrhosis. Gastroenterology 48:293-298, 1965.
109. Data VD, Sherlock S: Cholestyramine for long term relief of the pruritus complicating intrahepatic cholestasis. Gastroenterology 50:323-332, 1966.
110. Sharp HL, Carey JB Jr, White JG, et al: Cholestyramine therapy in patients with a paucity of intrahepatic bile ducts. J Pediat 71:723-736, 1967.
111. Faloon WW, Saunders DG: Chronic active hepatitis: Neomycin therapy and bile acid alteration. Gastroenterology 54:1232, 1968.